Loading reports catalog...
Loading reports catalog...
Access deep-dive research across global industry sectors to empower your strategic decision-making with data-driven insights.
Explore our comprehensive collection of healthcare market research reports, offering in-depth insights into the rapidly evolving global healthcare ecosystem. Our detailed analysis covers various segments, providing crucial medical device market analysis and identifying emerging trends across pharmaceuticals, biotechnology, and healthcare IT. As part of our specialized offerings, we provide granular data on niche sectors like the sterilization equipment market, ensuring industry leaders have the actionable intelligence needed for strategic planning and competitive benchmarking. Our reports deliver precise market sizing, growth forecasts, and competitive landscape assessments to guide your business decisions in the dynamic healthcare industry.
Showing 100 Results
The blood clot retrieval devices market size was estimated to be worth USD 2,394.57 million in 2025. The market is expected to expand at a CAGR of 14.6% from USD 2,724.78 million in 2026 to USD 9,318.13 million by 2035. The market growth is driven by the increasing prevalence of acute ischemic stroke, rising adoption of mechanical thrombectomy procedures, and growing emphasis on timely restoration of blood flow to improve patient outcomes. Additionally, expanding availability of advanced neurovascular treatment facilities, increasing investments in stroke care infrastructure, and favourable clinical evidence supporting clot retrieval therapies are further driving global market expansion.
The radiofrequency skin rejuvenation devices market size was estimated to be worth USD 812.12 million in 2025. The market is expected to expand at a CAGR of 9.1% from USD 877.09 million in 2026 to USD 1928.40 million by 2035. The market growth is driven by the increasing demand for non-invasive aesthetic procedures, rising consumer preference for skin tightening and anti-aging treatments, and growing awareness regarding collagen stimulation therapies. Additionally, advancements in radiofrequency energy delivery technologies, expanding medical aesthetic service offerings, and increasing beauty-conscious consumer trends are further driving global market expansion.
The global plaque modification devices market was estimated at USD 2,190.38 million in 2025 and is expected to grow at a CAGR of 8.6% from USD 2,361.23 million to USD 4,981.66 million in 2035. The plaque modification devices market is experiencing consistent expansion, fueled by the rising incidence of atherosclerotic cardiovascular disorders, the escalating burden of coronary artery disease, and the increasing use of sophisticated minimally invasive cardiovascular procedures. Moreover, the growth of cardiac catheterisation labs, escalating healthcare spending, and heightened awareness of early management of cardiovascular diseases are driving market expansion.
The global dental splints market size was evaluated at USD 515.83 million in 2025. The market is expected to grow at a CAGR of 6.8% from USD 546.16 million in 2026 to USD 989.73 million in 2035. The strong market growth is driven by the growing incidence of temporomandibular joint (TMJ) disorders, bruxism (teeth grinding), and heightened awareness of preventive dental treatment. Additionally, the growth of dental practices, rising healthcare spending, and heightened awareness about oral hygiene are driving market expansion.
The U.S. neurovascular devices market was estimated at USD 2.9 billion and is projected to grow at a CAGR of 5.5% from USD 3.01 billion in 2026 to USD 4.9 billion in 2035. The market is undergoing significant expansion, fueled by the growing incidence of neurological conditions and the escalating impact of cerebrovascular illnesses nationwide. Additionally, enhancing investments in stroke care facilities and neurointerventional laboratories, coupled with growing awareness of early detection and treatment, is fostering market expansion.
The U.S. nasal cannula market was estimated at USD 2.5 billion in 2025 and is expected to grow at a CAGR of 5.3% from USD 2.7 billion in 2026 to USD 4.2 billion in 2035. The market is experiencing consistent expansion, fueled by the rising incidence of respiratory conditions like chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and acute respiratory infections. Additionally, the increasing rate of hospital admissions caused by respiratory issues, particularly in emergency and intensive care environments, is elevating the need for nasal cannulas as a key oxygen delivery method. For instance, in situations involving pneumonia, complications from COVID-19, and recovery after surgery, nasal cannulas are commonly utilised in hospitals for providing low to moderate levels of oxygen.
Stay informed with updates on related market reports and key industry topics.